XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net income (loss) $ (32,412) $ (77,434) $ (56,998) $ (69,752)
Adjustments:        
Amortization 19,595 27,965 42,303 54,398
Accretion   3,529 8,066 6,992
Deferred income taxes (1,043) 704 5,408 (7,558)
Gain on debt extinguishment (2,961) 0 (2,961) 0
Fair value adjustments, net 3,922 62,810 (6,639) 49,066
Stock-based compensation 2,676 2,347 5,827 4,614
Gain (Loss) on Disposition of Assets 12,631 0 12,631 0
Inventory Write-down 1,627 9,219 14,740 16,814
Revenue Recognized (15,100) (241) (25,215) (556)
Foreign exchange and other 72 874 2,141 (466)
Changes in operating assets and liabilities:        
Receivables (913) (4,882) 2,137 4,218
Prepaid expenses and other current assets 4,260 3,523 3,764 3,014
Inventories (18,738) (11,263) (36,373) (28,935)
Accounts payable and accrued liabilities 61,708 5,493 35,563 (15,632)
Cash provided by (used in) operating activities 39,397 22,644 4,394 16,217
CASH FLOWS FROM INVESTING ACTIVITIES:        
Capital expenditures (85,581) (73,156) (159,629) (142,658)
Proceeds from the sale of assets 8,228 630 8,228 16,001
Sale of investments 1,783 0 41,558 0
Proceeds from Collection of Notes Receivable 0 0 5,000 0
Other (64) (10) (108) (21)
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (75,634) (72,536) (104,951) (126,678)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from Issuance of Common Stock 13,013 (62) 111,442 98,335
Issuance of notes and bank borrowings, net of issuance costs 150,000 70,000 225,000 155,000
Payments on long-term debt, capital leases, and associated costs (136,927) (19,037) (238,824) (122,304)
Other (225) (160) (2,322) (3,563)
CASH PROVIDED (USED IN) BY FINANCING ACTIVITIES 25,861 50,741 95,296 127,468
Effect of exchange rate changes on cash and cash equivalents 253 (13) 652 259
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (10,123) 836 (4,609) 17,266
Cash, cash equivalents and restricted cash at beginning of period 68,683 74,719 63,169 58,289
Cash, cash equivalents and restricted cash at end of period $ 58,560 $ 75,555 $ 58,560 $ 75,555